Alex Knapp is a Senior Editor at Forbes, specializing in health and science. With a focus on innovation and emerging technologies, Alex covers a wide range of topics including biotech, climate change, space exploration, and healthcare. His work has also been featured on KXLY-TV in Spokane, WA.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
International
Alex Knapp's coverage encompasses a variety of topics including healthcare, pharmaceuticals, sustainability, and innovation. He frequently focuses on groundbreaking startups, funding rounds, and innovative technologies within these fields.
Given the prevalence of press releases and data citations in his articles, it seems that Alex would be interested in receiving pitches related to new product launches or research findings supported by robust data. Additionally, he might also be open to stories about companies making significant contributions to healthcare or sustainability sectors.
As for government announcements being part of his coverage attributes at 11%, this suggests potential responsiveness to news regarding policy changes impacting the covered industries. Whether it’s advancements in biotech research or innovations within the space economy sector; they are all likely areas where Alex may respond well to well-pitched stories.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Plus: Why Nvidia, Google And Microsoft Are Betting Billions On Biotech's AI Future InnovationRx is your weekly digest of healthcare news.
Varda Space Industries successfully manufactured a sample of HIV medication on board its spacecraft and returned it safely to Earth.
Plus: Why Health Records Giant Epic Is Betting On Generative AI; This Startup Is One Step Closer To Making Drugs In Space
The pharmaceutical giant's new treatment, sotatercept, showed significant benefits for the thousands of patients suffering from pulmonary arterial hypertension in clinical trials.
By: Alex Knapp
Biotech startup eGenesis developed a gene-edited kidney that was successfully transplanted into a living patient last week. Its CEO says the company is just getting started.
Plus: eGenesis, the startup behind the first pig-human kidney transplant, is targeting hearts and livers next.
By: Alex Knapp
Biotech startup eGenesis developed a gene-edited kidney that was successfully transplanted into a living patient last week. Its CEO says the company is just getting started.
Eko Health, which has developed digital stethoscopes that use AI to detect different heart conditions, received clearance for an algorithm that can spot when hearts are pumping less than they should.
Plus: The consortium building the digital tools that hospitals actually need.
By: Katie Jennings, Alex Knapp
The scientists, doctors and entrepreneurs of this year's 30 Under 30 list for Science & Healthcare are working to improve healthcare and our understanding of the world around us. A
(833) 317-6278 
